Professor of Medicine, Mayo College of Medicine

Hematology

Vivek works in the field of Hematology. He over the years received 1 awards: "Fellow (FACP)". Vivek Roy is a published MD. He has 19 papers published. The most current publication "Success of an International Learning Health Care System inHematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case F..." Dr. Vivek Roy accepts Medicare.

Publications

---

• Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case F...
• Impact of access to NCI- and NCCN-designated Cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
• Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple my...
• Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
• Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single agent activity in patients with relapsed multiple myeloma.
• Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
• Financial Burden in Recipients of Allogeneic Hematopoietic Cell Transplantation.
• The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL Cells in vitro, as a single agent and in combination with other drugs.
• A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer: NCCTG Study N0338.
• Smoldering multiple myeloma requiring treatment: time for a new definition?
• Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.
• Immunomodulatory drugs in multiple myeloma.
• Subcutaneous panniculitis-like T-cell Lymphoma after rituximab.
• Autologous stem Cell transplant for Al amyloidosis.
• Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
• Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic Breast can...
• Artifactual laboratory abnormalities in patients with paraproteinemia.
• Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem Cell transpla...

Schools

---

• AllIndia Institute Of Medical Sciences AllIndia Institute Of Medical Sciences

• All India Institute Med Scis

• Mc Of Central Mass

• University Of Minnesota

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anemia
• Antiphospholipid Syndrome (APS)
• Bladder Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

• Blue Card PPO
• BlueDental Choice
• NetworkBlue
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• CoreSource
• GEHA
• Humana
• Medica
• Medicaid
• Medicare MCR
• Medico
• MultiPlan PPO
• PHCS Network PPO
• MVP Health Care
• National Elevator
• Tricare
• Choice Plus POS
• Options PPO
• United Healthcare

Awards

---

• Fellow (FACP)

Education

---

• University of Minnesota
• All India Institute of Medical Sciences

Hospital

---

• Mayo Clinic - Jacksonville, Florida

Drug Facts

---

NPI NUMBER		1215926944
NPPES Provider LastName		ROY
NPPES Provider FirstName		VIVEK
NPPES Provider ZIPCode		322241865
NPPES Provider State		FL
Specialty Description		Hematology/Oncology
Total Claim Count		387.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1215926944
Last Name Of The Provider	ROY
First Name Of The Provider	VIVEK
View All

Similar Doctors

---

	Dr. Mehdi M. Moezi, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith M. Justice, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey Dimascio, DO This Doctor is OpenDoctor Recommended.
	Dr. Mathew Luke, MD This Doctor is OpenDoctor Recommended.
	Dr. Suprith Badarinath, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason S. Starr, DO
	Dr. Marc A. Warmuth, MD This Doctor is OpenDoctor Recommended.
	Dr. Candido E. Rivera, MD This Doctor is OpenDoctor Recommended.
	Dr. Joel Stone, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas S. Davis, MD This Doctor is OpenDoctor Recommended.
	Dr. David M. Menke, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Elizabeth A. Johnson, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas G. Gaddis, MD This Doctor is OpenDoctor Recommended.
	Dr. Han W. Tun, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Morris S. Dees, MD This Doctor is OpenDoctor Recommended.
	Dr. David G. Hedrick, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog